<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C911D332-78ED-46E2-AB59-3E663AF502B3"><gtr:id>C911D332-78ED-46E2-AB59-3E663AF502B3</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Farmer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U952070003"><gtr:id>BA5BC122-6BE0-4B8B-8585-D83D1F7C1FEC</gtr:id><gtr:title>Molecular biomarkers of dose and effect of genotoxins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U952070003</gtr:grantReference><gtr:abstractText>Many aspects of our life-style have an impact on our risk of developing cancer, including exposure to certain environmental or dietary compounds. We plan to develop and validate biomarkers of the process of cancer induction (carcinogenesis), in order to identify the most important causative agents for cancer and to guide and monitor the effectiveness of treatment or of methods to prevent cancer development. These biomarkers are biochemical properties associated with the mechanism of carcinogenesis, and in particular we will examine damage to DNA, for which we will develop detection methods of extremely high sensitivity. We will also develop biomarkers to measure the biological changes in our cells that occur as a response to this DNA damage. We plan to apply these biomarker methods to populations exposed to environmental pollutants, to cancer patients, and to patients on cancer prevention trials, in order to validate these markers for more widespread use. Such studies should lead to the minimisation of exposure of the public to environmental carcinogens and the development of improved preventive measures, which should have a major impact on public health.</gtr:abstractText><gtr:technicalSummary>The principal objectives of this programme are: - to improve the analytical methods for adduct and metabolite characterisation and detection of site-specific carcinogen damage in macromolecules; - to apply new methods to detect human exposures to genotoxic compounds; - to investigate the biological consequences of adduct formation; and - to create a sample preparation laboratory for AMS, to be used for adduct determination following administration of low doses of 14C-labelled compounds; Accurate measurement of chemicals and their interaction products with biological systems, and of their biological effects, is essential for mechanistic studies in toxicology. Many of the tools for carcinogen biomonitoring available at present do not have the required sensitivity or ease of use for the study of the very low doses of carcinogens that are encountered by normal-living populations.We plan, therefore, to develop new analytical techniques for use both as molecular biomarkers of dose and effect and for application in other research programmes</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-15</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>256802</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_U952070003</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>